These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Malignant oncocytoma of the thyroid presenting with hepatic metastasis]. Lachachi F; Descottes B; Sodji M; Thognon P; Valleix D Ann Chir; 1998; 52(3):301-4. PubMed ID: 9752461 [No Abstract] [Full Text] [Related]
27. Report of a hürthle cell neoplasm in a peripubertal girl. Bremer AA; Feldman BJ; Iezza G; Clark OH; Rosenthal SM Thyroid; 2007 Feb; 17(2):175-8. PubMed ID: 17316121 [TBL] [Abstract][Full Text] [Related]
28. Ectopic thyrotropin secreting pituitary adenoma concomitant with papillary thyroid carcinoma: Case report. Yang J; Liu S; Yang Z; Shi YB Medicine (Baltimore); 2017 Dec; 96(50):e8912. PubMed ID: 29390279 [TBL] [Abstract][Full Text] [Related]
29. Pituitary gland metastasis from renal cell carcinoma presented as a non-functioning macroadenoma. Kramer CK; Ferreira N; Silveiro SP; Gross JL; Dora JM; Azevedo MJ Arq Bras Endocrinol Metabol; 2010; 54(5):498-501. PubMed ID: 20694412 [TBL] [Abstract][Full Text] [Related]
30. Coexistence of medullary thyroid carcinoma and recurrent non-functional pituitary adenoma: a case report. Bagherzadeh M; Aminorroaya A; Vafaeimanesh J; Mohajeri-Tehrani MR J Med Case Rep; 2018 Aug; 12(1):220. PubMed ID: 30107852 [TBL] [Abstract][Full Text] [Related]
31. Pituitary metastases from papillary carcinoma of thyroid: a case report and literature review. Chikani V; Lambie D; Russell A Endocrinol Diabetes Metab Case Rep; 2013; 2013():130024. PubMed ID: 24616765 [TBL] [Abstract][Full Text] [Related]
32. Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hürthle cell carcinoma. Ernaga Lorea A; Migueliz Bermejo I; Anda Apiñániz E; Pineda Arribas J; Toni García M; Martínez de Esteban JP; Insausti Serrano AM Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):136-142. PubMed ID: 29433918 [TBL] [Abstract][Full Text] [Related]
33. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration. Renshaw AA; Gould EW Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887 [TBL] [Abstract][Full Text] [Related]
34. [A case of metastatic lung tumor from an occult thyroid oncocytic carcinoma growing into the bronchial lumen]. Mitani A; Saku N; Hironaka M; Ohno S; Sohara Y; Saito K; Sugiyama Y Nihon Kokyuki Gakkai Zasshi; 2003 Nov; 41(11):822-6. PubMed ID: 14661556 [TBL] [Abstract][Full Text] [Related]
35. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553 [TBL] [Abstract][Full Text] [Related]
36. Malignant bronchial carcinoid tumor metastatic to the pituitary in a thyroid carcinoma patient: successful treatment with surgery, radiotherapy and somatostatin analog. Shimon I; Hadani M; Nass D; Zwas ST Pituitary; 2004; 7(1):51-7. PubMed ID: 15638299 [TBL] [Abstract][Full Text] [Related]
37. Thyroid Nodule Size as a Predictor of Malignancy in Follicular and Hurthle Neoplasms. Boonrod A; Akkus Z; Castro MR; Zeinodini A; Philbrick K; Stan M; Erickson D; Erickson B Asian Pac J Cancer Prev; 2021 Aug; 22(8):2597-2602. PubMed ID: 34452575 [TBL] [Abstract][Full Text] [Related]
40. The role of molecular testing in the diagnosis of medullary thyroid cancer: A case report of oncocytic medullary thyroid carcinoma and review of the literature. Spaulding SL; Ho R; Everest S; Chai RL Am J Otolaryngol; 2020; 41(1):102312. PubMed ID: 31727331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]